Arsenic Trioxide Induces Apoptosis in Human Platelets via C-Jun NH2-Terminal Kinase Activation
Arsenic trioxide (ATO), one of the oldest drugs in both Western and traditional Chinese medicine, has become an effective anticancer drug, especially in the treatment of acute promyelocytic leukemia (APL). However, thrombocytopenia occurred in most of ATO-treated patients with APL or other malignant...
Main Authors: | Wu, Yicun, Dai, Jin, Zhang, Weilin, Yan, Rong, Zhang, Yiwen, Ruan, Changgeng, Dai, Kesheng |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899281/ |
Similar Items
-
Calpain Activator Dibucaine Induces Platelet Apoptosis
by: Zhang, Weilin, et al.
Published: (2011) -
Lack of Correlation between Activation of Jun–NH2-terminal Kinase and Induction of Apoptosis after Detachment of Epithelial Cells
by: Khwaja, Asim, et al.
Published: (1997) -
PKC-δ mediates interferon-α-induced apoptosis through c-Jun NH2-terminal kinase activation
by: Yanase, Noriko, et al.
Published: (2012) -
Cloning and Functional Characterization of c-Jun NH2-Terminal Kinase from the Mediterranean Species of the Whitefly Bemisia tabaci Complex
by: Wang, Lan-Lan, et al.
Published: (2013) -
Krox-20 inhibits Jun-NH2-terminal kinase/c-Jun to control Schwann cell proliferation and death
by: Parkinson, David B., et al.
Published: (2004)